Stacy Cline Amin spoke to POLITICO about former Food and Drug Administration (FDA) commissioner Robert Califf returning for a second tour atop the agency after a lengthy search by the Biden administration for a permanent leader.
According to Stacy, it will be interesting to see how Califf responds to questions about real-world evidence and clinical trial design during his confirmation hearing.
"It was one of his top priorities as commissioner, but I have seen some comments from him more recently looking critically at some of the use of real-world evidence and different forms of clinical trials during COVID-19," Stacy said, citing a recent panel where Califf spoke.
Read the full article.
Originally published by POLITICO
Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.
© Morrison & Foerster LLP. All rights reserved